The Impact of Pharmacist Counseling on Quality of Life in Outpatients with Type 2 Diabetes Mellitus
Kata Kunci:
Pharmacist Counseling, Quality of Life, Type 2 Diabetes Mellitus, Outpatients.Abstrak
Type 2 Diabetes Mellitus is a chronic disease that requires long-term management and can reduce a patient's quality of life if not optimally managed. One effort that can be made to improve patient quality of life is through pharmacist counseling, which emphasizes medication education, increased therapy adherence, and the adoption of a healthy lifestyle. This study aims to determine the effect of pharmacist counseling on the quality of life of outpatients with Type 2 Diabetes Mellitus at Bhakti Kartini Hospital. This study used a quasi-experimental design with a pre-test and post-test approach. The study subjects were divided into two groups: an intervention group that received pharmacist counseling and a control group that did not receive counseling. Sampling was conducted using a purposive sampling method on 126 respondents, consisting of 63 patients in each intervention group and 63 patients in the control group. Data were obtained from medical records and routine patient visits and analyzed using SPSS version 29.0 using univariate analysis, the Shapiro-Wilk test, and the Mann-Whitney test. The results showed that outpatients with Type 2 Diabetes Mellitus at Bhakti Kartini Hospital were predominantly women aged 31–69, with a high school education, self-employment, duration of diabetes ≤ 5 years, and hypertension as the most common comorbidity. The analysis revealed a significant difference in quality of life between the control and intervention groups, indicating that pharmacist counseling plays a role in improving patients' quality of life. Furthermore, demographic factors did not significantly correlate with quality of life, suggesting that improvements in patient quality of life are more influenced by pharmacist counseling interventions and optimal therapy management.
Referensi
Amalia, D., Daulay, M. H., Panjaitan, H. O. A., Fransiska, F., & Nababan, T. (2024). Tingkat Pemahaman Pasien Tentang Proses Penanganan Penyakit Diabetes Mellitus Di RSU. Royal Prima Medan Tahun 2023. Jurnal Sains dan Teknologi, 5(3), 912-917.
Diantari, I. A. P. M., & Sutarga, I. M. (2019). Kepatuhan minum obat pada pasien diabetes melitus tipe 2 di wilayah kerja Puskesmas Tabanan II tahun 2019. Archive of Community Health, 6(2), 40.
Bekasi Health Office. (2021). Bekasi Health Profile 2020. 2021.
Fatiha, C. N., & Sabiti, F. B. (2021). Peningkatan Kepatuhan Minum Obat Melalui Konseling Apoteker pada Pasien Diabetes Mellitus Tipe 2 di Puskesmas Halmahera Kota Semarang. J Pharm Sci, 1(2), 42.
Hakim, A., Ismunandar, H., & Wahyuni, A. (2022). Manajemen Diabetes Melitus: An Update. Journal Medula, 12(1).
Komalasari, U., Adawiyah, S. R., &Windya, R. (2024). Asuhan Keperawatan Gerontik pada Pasien Diabetes Melitus Tipe 2 dengan Pemberian Jus Buah Naga Merah Terhadap Penurunan Kadar Glukosa Darah di Graha Marfati Tangerang. Med Nutr J Ilmu Kesehatan, 5(1), 25–31.
Laxmi, D., Kumala, S., Sarnianto, P., & Tarigan, A. (2021). Pengaruh edukasi farmasis terhadap hasil terapi dan kualitas hidup pasien prolanis diabetes melitus tipe 2. Jurnal Ilmiah Indonesia, 6(1), 154-172.
Lorber, D. (2014). Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes, metabolic syndrome and obesity: targets and therapy, 169-183.
Machado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R. (2007). Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Annals of pharmacotherapy, 41(10), 1569-1582.
Magliano, D. J., & Boyko, E. J. (2021). IDF diabetes atlas.
MOH. (2018). Riset Kesehatan Dasar 2018. Jakarta: Badan Penelitian dan Pengembangan Kesehatan.
Mohammad, A., Chand, M. K., Beg, M. A., & Bawa, S. (2019). Comparative Evaluation of DPP-IV Inhibitors and other Oral Hypoglycaemic Agents used Either Alone or in Combination with Reference to Glycemic Targets in Patients with Type 2 Diabetes Mellitus.
Morgado, M., Rolo, S., & Castelo-Branco, M. (2011). Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. International journal of clinical pharmacy, 33(1), 132-140.
Polgreen, L. A., Han, J., Carter, B. L., Ardery, G. P., Coffey, C. S., Chrischilles, E. A., & James, P. A. (2015). Cost-effectiveness of a physician–pharmacist collaboration intervention to improve blood pressure control. Hypertension, 66(6), 1145-1151.
Presley, B., Groot, W., & Pavlova, M. (2019). Pharmacy-led interventions to improve medication adherence among adults with diabetes: a systematic review and meta-analysis. Research in Social and Administrative Pharmacy, 15(9), 1057-1067.
Rammang, S., & Reza, N. N. (2023). Pengendalian diabetes melitus melalui edukasi dan pemeriksaan kadar gula darah sewaktu. Jurnal Pendidikan Tambusai, 7(1), 133-137.
Sastroasmoro, S., & Ismael, S. (2014). Dasar-dasar metodologi penelitian klinis.
Simon, M. A., Raja, B. Y., Varughese, P. C., Daniel, L. M., Sowjanya, K., Rathinam, K. K., & Kumar, P. (2021). Pharmacist led intervention towards management of type 2 diabetes mellitus and assessment of patient satisfaction of care-A prospective, randomized controlled study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(5), 102208.
Soelistijo, S., Lindarto, D., Decroli, E., Permana, H., Sucipto, K. W., Kusnadi, Y., & Ikhsan, R. (2021). Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa di Indonesia 2021. Global Initiative for Asthma, 46.











